US Patent Issued to Societe des Produits Nestle on Feb. 24 for "Dosage form with sustained release melatonin pellets" (Florida Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,310, issued on Feb. 24, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Dosage form with sustained release melatonin pellets" was invented by Syed M. Shah (Boca Raton, Fla.) and Daniel Hassan (Boca Raton, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition comprises a therapeutically effective oral pharmaceutical dosage form. The dosage form includes an aqueous carrier material having an acidic pH and a plurality of individual pellets having a first dose of melatonin therein. The individual pellets comprises (i) a solid core; (ii) an active coating over the solid core, the active coating including melatonin and ...